Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2016 Sep 1;168:22–29. doi: 10.1016/j.drugalcdep.2016.08.631

Table 3.

Associations between Mental Health Conditions and Self-reported Inability to Access Health and Social Services in the Previous 6 Months of Assessment, byaMental Health Condition Indicators and bybTreatment Access.

Unadjusted OR
(95% CI)
P-
value
cAdjusted OR
(95% CI)
P-
value
Mental health condition indicators, L6M

Diagnosis with a mental illness 1.86 (1.68–2.06) <0.001 1.41 (1.26–1.58) <0.001
Receipt of mental health
treatment
1.34 (1.22–1.47) <0.001 1.31 (1.19–1.45) <0.001
Suicide attempt or ideation 1.82 (1.61–2.06) <0.001 1.48 (1.31–1.68) <0.001
Hospitalization for a mental
illness
1.87 (1.57–2.22) <0.001 1.35 (1.12–1.61) 0.001
Agonist treatment accessd,e
PWID on agonist treatment,
L6M
1.58 (1.41, 1.78) <0.001 1.41 (1.25, 1.59) <0.001
PWID not on agonist treatment,
L6M
1.68 (1.48, 1.91) <0.001 1.51 (1.33, 1.72) <0.001
ART accesse
HIV-positive PWID on ART,
current
1.38 (1.14, 1.66) 0.001 1.31 (1.05, 1.62) 0.015
HIV-positive PWID not on ART,
current
1.75 (1.33, 2.29) <0.001 1.45 (1.06, 1.99) 0.021

Abbreviations: OR: odds ratio; CI: confidence interval; PWID: people who inject drugs; L6M: last six months; ART: antiretroviral therapy.

a

Analysis was repeated for four self-reported mental health condition indicators to examine the associations between different mental health condition indicators and the outcome.

b

Analysis was repeated for PWID by agonist treatment access, and among HIV-positive PWID by ART access.

c

Adjusted for HIV, HCV, age, gender, race, daily heroin use, daily stimulants use, daily prescription opioid use, overdose, alcohol binge, incarceration, homelessness, employment, sex work, drug dealing, victim of violence, reside in DTES, and calendar year.

d

Agnoist treatment includes methadone program, cocaine treatment program, detox centre, in-patient and out-patient treatment centre and others.

e

No statistically-significant differences in the adjusted odds ratios by agonist treatment access (P = 0.42) and ART access (P = 0.92).